Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Saskia Z. Rittersma"'
Autor:
Nicole D. van Hemert, Pieter R. Stella, Rik Rozemeijer, Mèra Stein, Peter Frambach, Adriaan O. Kraaijeveld, Saskia Z. Rittersma, Timion A. Meijs, Geert E.H. Leenders, Pim van der Harst, Pierfrancesco Agostoni, Michiel Voskuil
Publikováno v:
American Heart Journal Plus, Vol 24, Iss , Pp 100227- (2022)
Objectives: In an all-comers cohort undergoing percutaneous coronary intervention (PCI), we aimed to assess prevalence of high bleeding risk (HBR) patients and impact of HBR and dual antiplatelet therapy (DAPT) on clinical events. Background: HBR rep
Externí odkaz:
https://doaj.org/article/989bc94364eb4298b4ffdbc17d7e0e76
Autor:
Peter Frambach, Pierfrancesco Agostoni, Michiel Voskuil, ReCre Study Investigators, Mera Stein, Nicole D. van Hemert, Pim van der Harst, Adriaan O. Kraaijeveld, Bruno Pereira, Pieter R. Stella, Leo Timmers, Rik Rozemeijer, Saskia Z. Rittersma, Geert E. Leenders
Publikováno v:
JACC: Cardiovascular Interventions. 14:2477-2486
Objectives The aim of this analysis was to assess long-term clinical outcomes of the polymer-free Amphilimus-eluting stent (PF-AES) compared with a latest generation permanent-polymer drug-eluting stent (DES) in an all-comers population. Background P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18e9b0b0a5d07d48a03b2f25ebfd7fbe
https://doi.org/10.1016/j.jcin.2021.08.078
https://doi.org/10.1016/j.jcin.2021.08.078
Autor:
C. Wing Wong, Adriaan O. Kraaijeveld, Saskia Z. Rittersma, Pieter A. Doevendans, Michiel Voskuil, M. L. Bots, Stefan Koudstaal, Pieter R. Stella, Rik Rozemeijer, Geert E. Leenders, Leo Timmers
Publikováno v:
Netherlands Heart Journal
Netherlands Heart Journal, 27(6), 321. Bohn Stafleu van Loghum
Netherlands Heart Journal, 27(6), 321. Bohn Stafleu van Loghum
Objective We sought to determine the incidence, angiographic predictors, and impact of stent thrombosis (ST). Background Given the high mortality after ST, this study emphasises the importance of ongoing efforts to identify angiographic predictors of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e3c04ab30c478d7caa1a7e790ce65b
http://europepmc.org/articles/PMC6533324
http://europepmc.org/articles/PMC6533324
Autor:
Pieter R. Stella, Leo Timmers, Stefan Koudstaal, Mera Stein, Geert E. Leenders, Michiel Voskuil, Rik Rozemeijer, Peter Frambach, Bruno Pereira, Rutger van den Bor, Adriaan O. Kraaijeveld, Kit C.B. Roes, Pieter A. Doevendans, Saskia Z. Rittersma, Pierfrancesco Agostoni
Publikováno v:
Circulation. 139:67-77
Background: Polymer-free amphilimus-eluting stents (PF-AES) represent a novel elution technology in the current era of drug-eluting stents. The clinical safety and efficacy of PF-AES as compared with latest-generation permanent-polymer zotarolimus-el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::749bca92f1c12cf3498d9b75f5cc1e5e
https://doi.org/10.1161/circulationaha.118.037707
https://doi.org/10.1161/circulationaha.118.037707
Autor:
Nicole D, van Hemert, Michiel, Voskuil, Rik, Rozemeijer, Mèra, Stein, Peter, Frambach, Bruno, Pereira, Saskia Z, Rittersma, Adriaan O, Kraaijeveld, Geert E H, Leenders, Leo, Timmers, Pim, van der Harst, Pierfrancesco, Agostoni, Pieter R, Stella
Publikováno v:
JACC. Cardiovascular interventions. 14(22)
The aim of this analysis was to assess long-term clinical outcomes of the polymer-free Amphilimus-eluting stent (PF-AES) compared with a latest generation permanent-polymer drug-eluting stent (DES) in an all-comers population.PF-AES possess multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fbddcac3a7ef6f5c31f0fc0c12514261
https://pubmed.ncbi.nlm.nih.gov/34794655
https://pubmed.ncbi.nlm.nih.gov/34794655
Autor:
Nicole D. van Hemert, Pim van der Harst, Michiel Voskuil, Peter Frambach, Adriaan O. Kraaijeveld, Pierfrancesco Agostoni, Saskia Z. Rittersma, Rik Rozemeijer, Geert E. Leenders, ReCre Study Investigators, Pieter R. Stella, Mera Stein
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 99(2)
Objectives The purpose of this analysis was to compare target-lesion failure (TLF) of a permanent polymer zotarolimus-eluting stent (PP-ZES) versus a polymer-free amphilimus-eluting stent (PF-AES) in diabetics. Background The improvement of outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3948a896ae8ec4d2c4509a344eadde21
https://pubmed.ncbi.nlm.nih.gov/33811730
https://pubmed.ncbi.nlm.nih.gov/33811730
Autor:
Rik Rozemeijer, Michiel Voskuil, Geert E. Leenders, Pierfrancesco Agostoni, Saskia Z. Rittersma, Adriaan O. Kraaijeveld, Peter Frambach, Nicole D. van Hemert, Pieter R. Stella, Pim van der Harst, Mera Stein
Publikováno v:
Cardiovascular Revascularization Medicine. 28:S20-S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5155943e356e2505e15f9519ff9b4295
https://doi.org/10.1016/j.carrev.2021.06.048
https://doi.org/10.1016/j.carrev.2021.06.048
Autor:
Miranda C Kramer, Allard C van der Wal, Karel T Koch, Saskia Z Rittersma, Xiaofei Li, Hanneke P Ploegmakers, José P Henriques, René J van der Schaaf, Jan Baan, Marije M Vis, Martin G Meesterman, Jan J Piek, Jan G Tijssen, Robbert J de Winter
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5817 (2009)
BACKGROUND: Plaque disruption with superimposed thrombus is the predominant mechanism responsible for the onset of acute coronary syndromes. Studies have shown that plaque disruption and thrombotic occlusion are frequently separated in time. We estab
Externí odkaz:
https://doaj.org/article/033b2c8f89b44baebccdde72e3a588fc
Autor:
Rik Rozemeijer, Pierfrancesco Agostoni, Pieter A. Doevendans, Ramón Rodríguez-Olivares, Leo Timmers, Saskia Z. Rittersma, Peter Frambach, Mera Stein, Bruno Pereira, Adriaan O. Kraaijeveld, Michiel Voskuil, Pieter R. Stella
Publikováno v:
Catheterization and Cardiovascular Interventions. 91:410-416
Background Amphilimus sirolimus-eluting stents (A-SES) represent a novel elution technology in the current era of drug-eluting stents with promising results in patients with diabetes mellitus. At present no large trial has been designed to evaluate c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102d3d2076ed43ad0ec0357d908f7bdf
https://doi.org/10.1002/ccd.27142
https://doi.org/10.1002/ccd.27142
Autor:
Rik Rozemeijer, Adriaan O. Kraaijeveld, Pieter R. Stella, Stefan Koudstaal, Pieter A. Doevendans, Saskia Z. Rittersma, Ivar G van Muiden, Geert E. Leenders, Leo Timmers, Michiel Voskuil
Publikováno v:
Catheterization and Cardiovascular Interventions, 94(1), 61. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
Background Polymer‐free amphilimus‐eluting stents (PF‐AES) represent a novel elution‐technology in coronary stenting. We aimed to assess 1‐year clinical outcomes of PF‐AES as compared to latest‐generation permanent polymer zotarolimus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687544ee1e5b444c7d82dc7fce52e807
https://dspace.library.uu.nl/handle/1874/383512
https://dspace.library.uu.nl/handle/1874/383512
